Overactive Bladder - Results from #120

Title: Associations between Urinary Concentrations of Polycyclic Aromatic Hydrocarbons (PAHs) and Overactive Bladder (OAB) in United States Adults: Data from the National Health and Nutrition Examination Survey (NHANES) 2005-2016. March 31, 2024

CamiCon study: Evaluation of a new tool for automated and connected voiding calendar. March 31, 2024

Urodynamic insights: exploring the relationship between detrusor overactivity and pelvic organ prolapse in women with urge incontinence. March 31, 2024

Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including β3-Adrenoceptor Agonists -Basic Research Perspectives. March 24, 2024

Efficacy and safety of tibial nerve stimulation using a wearable device for overactive bladder. March 24, 2024

Factors Associated With Onabotulinum Toxin-A Discontinuation in a Diverse Urban Population. March 24, 2024

Variation in Defining Retention After Onabotulinum Toxin A for Overactive Bladder: A Systematic Review. March 24, 2024

Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis. March 24, 2024

Pilot Study of a Digital Behavioral Therapy for Overactive Bladder in Women. March 24, 2024

The role of botulinum toxin in the management of nonneurogenic overactive bladder in children: Highlights for clinical practice. A systematic review. March 24, 2024

Overactive Bladder Medication Access March 19, 2024

Associations between serum testosterone levels and overactive bladder in women: a cross-sectional research of NHANES 2011 to 2016. March 17, 2024

Pain Related to Intradetrusor BotulinumtoxinA: A Randomized Clinical Trial. March 17, 2024

A Comparison of U.S. Individual and Family Plan Medication Coverage for Overactive Bladder. March 17, 2024

Understanding the Pursuit of Third-Line Therapies for Overactive Bladder: A Mixed Methods Study. March 17, 2024

The Impact of an Overactive Bladder Care Pathway on Longitudinal Patient Management. March 17, 2024

Multicomponent Intervention for Overactive Bladder in Women: A Randomized Clinical Trial. March 14, 2024

Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial. March 10, 2024

Radiofrequency as the New Opportunity in Treating Overactive Bladder and Urge Urinary Incontinence-A Single-Arm Pilot Study. March 10, 2024

A Double-blind, Randomised Four-way Crossover Study to Compare the Effects of Fesoterodine 4 and 8 mg Once Daily and Qxybutynin 5 mg Twice Daily After Steady-state Dosing Versus Placebo on Cognitive Function in Overactive Bladder-wet Patients over the Age March 10, 2024

Page 7 of 122